Works by Chow, Kar

Results: 14
    1
    2

    Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.

    Published in:
    Viruses (1999-4915), 2023, v. 15, n. 8, p. 1699, doi. 10.3390/v15081699
    By:
    • Mediavilla, José R.;
    • Lozy, Tara;
    • Lee, Annie;
    • Kim, Justine;
    • Kan, Veronica W.;
    • Titova, Elizabeth;
    • Amin, Ashish;
    • Zody, Michael C.;
    • Corvelo, André;
    • Oschwald, Dayna M.;
    • Baldwin, Amy;
    • Fennessey, Samantha;
    • Zuckerman, Jerry M.;
    • Kirn, Thomas;
    • Chen, Liang;
    • Zhao, Yanan;
    • Chow, Kar Fai;
    • Maniatis, Tom;
    • Perlin, David S.;
    • Kreiswirth, Barry N.
    Publication type:
    Article
    3

    Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 6, p. 487, doi. 10.1002/ajh.23983
    By:
    • Mato, Anthony R.;
    • Foon, Kenneth A.;
    • Feldman, Tatyana;
    • Schuster, Stephen J.;
    • Svoboda, Jakub;
    • Chow, Kar Fai;
    • Valentinetti, Marisa;
    • Mrkulic, Mary;
    • Azzollini, Kelly;
    • Gadaleta, Gabriella;
    • Bhattacharyya, Pritish K.;
    • Zenreich, Joshua;
    • Pascual, Lauren-Nicole;
    • Yannotti, Kara;
    • Kdiry, Sabrina;
    • Howlett, Christina;
    • Strelec, Lauren;
    • Porter, David;
    • Bejot, Coleen;
    • Goy, André
    Publication type:
    Article
    4
    5
    6
    7
    8

    Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 12, p. 2606, doi. 10.3109/10428194.2013.783909
    By:
    • Mato, Anthony;
    • Feldman, Tatyana;
    • Zielonka, Tania;
    • Singavi, Arun;
    • Gadaletta, Gabriella;
    • Waksmundzki, Kathryn;
    • Bhattacharyya, Pritish;
    • Chow, Kar Fai;
    • Yang, Xiao;
    • Panush, David;
    • Agress, Harry;
    • Rosario, Maria;
    • Howlett, Christina;
    • Pecora, Andrew;
    • Goy, Andre
    Publication type:
    Article
    9

    Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide ( RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.

    Published in:
    British Journal of Haematology, 2014, v. 166, n. 1, p. 77, doi. 10.1111/bjh.12846
    By:
    • Feldman, Tatyana;
    • Mato, Anthony R.;
    • Chow, Kar F.;
    • Protomastro, Ewelina A.;
    • Yannotti, Kara M. L.;
    • Bhattacharyya, Pritish;
    • Yang, Xiao;
    • Donato, Michele L.;
    • Rowley, Scott D.;
    • Carini, Carolanne;
    • Valentinetti, Marisa;
    • Smith, Judith;
    • Gadaleta, Gabriella;
    • Bejot, Coleen;
    • Stives, Susan;
    • Timberg, Mary;
    • Kdiry, Sabrina;
    • Pecora, Andrew L.;
    • Beaven, Anne W.;
    • Goy, Andre
    Publication type:
    Article
    10

    Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV‐CATCHER): A customizable purification assay designed for small‐RNA biomarker identification and evaluation of circulating small‐EVs.

    Published in:
    Journal of Extracellular Vesicles, 2021, v. 10, n. 8, p. 1, doi. 10.1002/jev2.12110
    By:
    • Mitchell, Megan I.;
    • Ben‐Dov, Iddo Z.;
    • Liu, Christina;
    • Ye, Kenny;
    • Chow, Kar;
    • Kramer, Yael;
    • Gangadharan, Anju;
    • Park, Steven;
    • Fitzgerald, Sean;
    • Ramnauth, Andrew;
    • Perlin, David S.;
    • Donato, Michele;
    • Bhoy, Emily;
    • Manouchehri Doulabi, Ehsan;
    • Poulos, Michael;
    • Kamali‐Moghaddam, Masood;
    • Loudig, Olivier
    Publication type:
    Article
    11
    12
    13
    14